Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities

被引:24
|
作者
Delgado, Carolina [1 ,2 ,3 ]
Vergara, Rodrigo C. [3 ,4 ]
Martinez, Melissa [1 ,2 ]
Musa, Gada [5 ,6 ,7 ,8 ]
Henriquez, Fernando [5 ,6 ,7 ,8 ]
Slachevsky, Andrea [3 ,5 ,6 ,7 ,8 ]
机构
[1] Hosp Clin Univ Chile, Dept Neurol, Santos Dumont 999, Santiago 8380456, Chile
[2] Hosp Clin Univ Chile, Dept Neurosurg, Santos Dumont 999, Santiago 8380456, Chile
[3] Univ Chile, Fac Med, Dept Neurosci, Santiago, Chile
[4] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile
[5] Gerosci Ctr Brain Hlth & Metab GERO, Ave Salvador 486, Santiago, Chile
[6] Univ Chile, Fac Med, Neuropsychol & Clin Neurosci Lab LANNEC, Physiopathol Dept,ICBM,East Neurosci Dept, Santiago, Chile
[7] Hosp del Salvador, Memory & Neuropsychiat Clin CMYN, Neurol Dept, Santiago, Chile
[8] Univ Chile, Santiago, Chile
关键词
Activities of daily living; Alzheimer's disease; apathy; cognitive decline; depression; disability; elderly; memory; neuropsychiatric symptoms; MILD COGNITIVE IMPAIRMENT; DAILY LIVING QUESTIONNAIRE; INSTRUMENTAL ACTIVITIES; DIAGNOSTIC-CRITERIA; OLDER-ADULTS; ASSOCIATION WORKGROUPS; NATIONAL INSTITUTE; INCIDENT DEMENTIA; APATHY; VALIDATION;
D O I
10.3233/JAD-180771
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Neuropsychiatric symptoms and cognitive impairment are independent contributors of functional impairment in activities of daily living (ADL) in Alzheimer's disease (AD) patients. ADL could be divided according to its complexity in three subdomains: basic (BADL), instrumental (IADL), and advanced (a-ADL). Objective: Studying the cognitive and neuropsychiatric determinants of BADL, IADL, and a-ADL in normal cognitive elders and AD patients. Methods: 144 subjects were graduated using the clinical dementia rating (CDR) in CDR = 0, n= 52 (control group) and 92 AD patients CDR = 0.5, n= 34 and CDR = 1&2, n= 58. They were assessed with measures of cognitive performance and neuropsychiatric symptoms that were included in regression models to measure the best predictors for each ADL subdomain at every CDR status. Results: AD patients were significantly older, and had significantly more severe functional impairment, neuropsychiatric symptoms, and cognitive decline than controls. The best predictors of functional impairment in controls and CDR = 0.5 AD patients were neuropsychiatric symptoms; in the CDR 0.5 patients, apathy severity was the most important determinant of IADL and a-ADL impairment. While in the CDR 1&2 AD patients, cognitive impairment was the principal determinant of functional impairment, being memory the best determinant of IADL and a-ADL impairment, while global cognition was of BADL impairment. Conclusions: The contribution of cognitive impairment and neuropsychiatric symptoms varied according to the subdomain of ADL, and the CDR. In very mild AD and controls the neuropsychiatric symptoms are the best predictors of more complex ADL impairment, while cognitive impairment is more important at mild to moderate states of AD.
引用
收藏
页码:381 / 392
页数:12
相关论文
共 50 条
  • [11] Neuropsychiatric Symptoms and Regional Neocortical Atrophy in Mild Cognitive Impairment and Alzheimer's Disease
    Rafii, Michael S.
    Taylor, Curtis S.
    Kim, Hyun T.
    Desikan, Rahul S.
    Fleisher, Adam S.
    Katibian, David
    Brewer, James B.
    Dale, Anders M.
    Aisen, Paul S.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2014, 29 (02): : 159 - 165
  • [12] Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease
    Teng, Edmond
    Lu, Po H.
    Cummings, Jeffrey L.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2007, 24 (04) : 253 - 259
  • [13] Treatment of neuropsychiatric symptoms in Alzheimer's disease
    Kaufer, A
    REVISTA DE NEUROLOGIA, 2002, 35 (09) : 846 - +
  • [14] White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease
    Misquitta, Karen
    Dadar, Mahsa
    Collins, D. Louis
    Tartaglia, Maria Carmela
    NEUROIMAGE-CLINICAL, 2020, 28
  • [15] PSYCHEDELICS FOR THE NEUROPSYCHIATRIC SYMPTOMS OF ALZHEIMER'S DISEASE
    Sarangi, Ashish
    Akinkunmi, Omotola
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2023, 31 (03): : S44 - S45
  • [16] Assessing the Stability of Clusters of Neuropsychiatric Symptoms in Alzheimer's Disease and Mild Cognitive Impairment
    Scarfo, Sara
    Moshfeghi, Yashar
    Mcgeown, William J.
    CURRENT ALZHEIMER RESEARCH, 2024, 21 (04) : 258 - 275
  • [17] Relationship of cognitive impairment and neuropsychiatric symptoms with functional disability in Parkinson's disease
    Chahine, L.
    Hurtig, H.
    Brennan, L.
    Colcher, A.
    Dahodwala, N.
    Darin, A.
    Horn, S.
    Stern, M.
    Tran, B.
    Siderowf, A.
    MOVEMENT DISORDERS, 2011, 26 : S149 - S149
  • [18] Interventions for Neuropsychiatric Symptoms in Neurocognitive Impairment Due to Alzheimer's Disease: A Review of the Literature
    McClam, Tamela D.
    Marano, Christopher M.
    Rosenberg, Paul B.
    Lyketsos, Constantine G.
    HARVARD REVIEW OF PSYCHIATRY, 2015, 23 (05) : 377 - 393
  • [19] Neuropsychiatric Symptoms and Functional Status in Alzheimer's Disease and Vascular Dementia Patients
    D'Onofrio, Grazia
    Sancarlo, Daniele
    Panza, Francesco
    Copetti, Massimiliano
    Cascavilla, Leandro
    Paris, Francesco
    Seripa, Davide
    Matera, Maria G.
    Solfrizzi, Vincenzo
    Pellegrini, Fabio
    Pilotto, Alberto
    CURRENT ALZHEIMER RESEARCH, 2012, 9 (06) : 759 - 771
  • [20] Neuropsychiatric Symptoms and Functional Decline in Alzheimer's Disease and Lewy Body Dementia
    German Borda, Miguel
    Aarsland, Dag
    Alejandro Tovar-Rios, Diego
    Giil, Lasse M.
    Ballard, Clive
    Camila Gonzalez, Maria
    Bronnick, Kolbjorn
    Alves, Guido
    Oppedal, Ketil
    Soennesyn, Hogne
    Vik-Mo, Audun Osland
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2020, 68 (10) : 2257 - 2263